Versartis (VSAR)

Add to Watchlists
Create an Alert
21.15 +1.55  +7.91% NASDAQ Sep 20, 14:25 Delayed 2m USD
View Full Chart
VSAR Price Chart
View All Events

VSAR Events

Date Type Description
07/27/2017 Earnings Versartis Inc Second Quarter Earnings Results in 2017
02/21/2017 Earnings Versartis Inc Fourth Quarter Earnings Results in 2016
11/03/2016 Earnings Versartis Inc Third Quarter Earnings Results in 2016
View All Performance Charts

VSAR Total Returns Comparison


VSAR One Page Reports



  • URL:
  • Investor Relations URL:
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Next Earnings Release: N/A
  • Last Earnings Release: Jul. 27, 2017
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Versartis Inc is an endocrine-focused biopharmaceutical company initially developing long-acting recombinant human growth hormone for the treatment of growth hormone deficiency.

VSAR Comparables


VSAR Excel Add-In Codes

  • Name: =YCI("VSAR","name")
  • Description: =YCI("VSAR","description")
  • Sector: =YCI("VSAR","sector")
  • Industry: =YCI("VSAR","industry")
  • Est. Current Fiscal Year End: =YCI("VSAR","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.




Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.